501 filings
Page 3 of 26
EFFECT
ENDV
Endonovo Therapeutics, Inc.
17 Jul 20
Notice of effectiveness
12:15am
424B3
ENDV
Endonovo Therapeutics, Inc.
16 Jul 20
Prospectus supplement
11:35am
CORRESP
ENDV
Endonovo Therapeutics, Inc.
13 Jul 20
Correspondence with SEC
12:00am
S-1/A
ENDV
Endonovo Therapeutics, Inc.
IPO registration (amended)
10 Jul 20
4:31pm
4
Collier Alan Brian
7 Jul 20
ENDONOVO THERAPEUTICS / Alan Brian Collier ownership change
1:47pm
UPLOAD
ENDV
Endonovo Therapeutics, Inc.
30 Jun 20
Letter from SEC
12:00am
S-1
ENDV
Endonovo Therapeutics, Inc.
IPO registration
23 Jun 20
4:01pm
10-Q
2020 Q1
ENDV
Endonovo Therapeutics, Inc.
Quarterly report
12 Jun 20
12:00am
EFFECT
ENDV
Endonovo Therapeutics, Inc.
9 Jun 20
Notice of effectiveness
12:15am
RW WD
ENDV
Endonovo Therapeutics, Inc.
2 Jun 20
Withdrawal of registration withdrawal request
7:58am
POS AM
ENDV
Endonovo Therapeutics, Inc.
2 Jun 20
Prospectus update (post-effective amendment)
6:04am
RW
ENDV
Endonovo Therapeutics, Inc.
29 May 20
Registration withdrawal request
5:30pm
8-K
ENDV
Endonovo Therapeutics, Inc.
26 May 20
Entry into a Material Definitive Agreement
12:00am
8-K
ENDV
Endonovo Therapeutics, Inc.
19 May 20
Other Events
2:07pm
NT 10-Q
ENDV
Endonovo Therapeutics, Inc.
14 May 20
Notice of late quarterly filing
5:16pm
10-K
2019 FY
ENDV
Endonovo Therapeutics, Inc.
Annual report
4 May 20
12:00am
8-K
ENDV
Endonovo Therapeutics, Inc.
10 Apr 20
Other Events
9:29am
NT 10-K
ENDV
Endonovo Therapeutics, Inc.
26 Mar 20
Notice of late annual filing
11:30am
8-K
ENDV
Endonovo Therapeutics, Inc.
2 Mar 20
Other Events
6:10am
4
ENDV
Endonovo Therapeutics, Inc.
26 Feb 20
ENDONOVO THERAPEUTICS / Alan Brian Collier ownership change
5:15pm